Clinical Trials Directory

Trials / Unknown

UnknownNCT02169843

Small Doses of Dexmedetomidine for Emergence Agitation

Influence of Small Doses Dexmedetomidine to the Elderly Patients' Emergence Agitation

Status
Unknown
Phase
Phase 4
Study type
Interventional
Enrollment
80 (estimated)
Sponsor
Tang-Du Hospital · Academic / Other
Sex
All
Age
65 Years
Healthy volunteers
Not accepted

Summary

Dexmedetomidine Hydrochloride is a kind of high selectivity alpha 2 agonists adrenaline, can inhibit the activity of sympathetic nerve, and reduce the adverse effects of stress reaction in anesthesia recovery period.Literatures have been reported that Dex can reduce the rate of emergence agitation of children and adults,especially in elderly patients(\>64 years) after using sevoflurane anesthesia.

Conditions

Interventions

TypeNameDescription
DRUGSevofluraneinhale Sevoflurane
DRUGDexmedetomidineintravenous pumping Dexmedetomidine 0.2µg/kg/h
DRUGPlacebo(for Dexmedetomidine)normal saline mimic Dexmedetomidine, intravenous pumping 0.05ml/kg/h

Timeline

Start date
2014-05-01
Primary completion
2014-10-01
Completion
2014-10-01
First posted
2014-06-23
Last updated
2014-06-23

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT02169843. Inclusion in this directory is not an endorsement.